23 Feb Aspen Neuroscience
Damien McDevitt, Ph.D., CEO
Oct. 12 | 4:15pm | BlueRock Therapeutics Ballroom
San Diego, CA
Aspen Neuroscience is a development-stage, private biotechnology company focused on personalized autologous cell therapies. The company is developing induced-pluripotent stem cells to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease and extending across the brain and affected organs. A leading iPSC platform company, Aspen combines stem cell biology with the latest artificial intelligence and genomic approaches to investigate patient-specific, restorative treatments. The company has developed a best-in-class platform to create and characterize pluripotent-derived cell medicines, which includes in-house bioinformatics, manufacturing, and QC.